Position in ATYR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,181
-$440 QoQ
Shares Held
1,979
-4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 90 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NFSG Corp holds $2,875,353 across 46 Biotechnology names. ATYR ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,061 | $1,643,603 | |
| 2 | OMER |
Omeros Corp
|
46,210 | $439,457 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
11,925 | $201,771 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
1,003 | $87,210 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
1,700 | $66,317 | |
| 6 | GLSI |
Greenwich LifeSciences, Inc.
|
2,100 | $49,266 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
1,000 | $42,910 | |
| 8 | PALI |
Palisade Bio, Inc.
|
20,250 | $42,322 |
All Filings in ATYR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,181 | 1,979 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,621 | 2,079 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,818 | 3,600 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $360 | 500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,535 | 500 | Shares | Sole | 2025-08-19 | |
| No filing history on record for this holder in this stock. | ||||||